Thomson / Proc Natl Acad Sci U S A / CSF SA / SHIV / Fiscus SA / Subtype AE / Creative Commons / /
Country
Australia / /
Currency
USD / / /
Event
FDA Phase / /
Facility
University of New South Wales / University of Melbourne / University of Pennsylvania School / /
IndustryTerm
reagents/materials/analysis tools / /
MedicalCondition
primary HIV infection / DF / overall disease / HIV viremia / WT viremia / HIV / dual infection / less pathogenic infections / very early acute infection / immunodeficiency virus infection / primary infection / very early infection / chronic stage / HIV infections / Infection Liyen Loh1 / experimental SIV infection / infections / acute and chronic infection / disease / chronic human immunodeficiency virus type / experimental infection / end stage disease / SHIVmn229 infection / Viremia / early infection / faster disease / AIDS / EM infection / infection / SIV infection / chronic infection / simian HIV infection / SIVmac239 infection / acute infection / human papilloma virus-simian/human immunodeficiency virus virus-likeparticle vaccines / early HIV infection / every HIV infection / frequently observed following infection / /
MedicalTreatment
vaccination / /
NaturalFeature
dT ~l{dT T{bW WT{bM MT / /
Organization
University of Pennsylvania School of Medicine / MB JP / CSIRO / University of New South Wales / Sydney / University of Melbourne / Melbourne / Department of Microbiology and Immunology / Center for Vascular Research / /
Person
Susan Ross / Equation / /
Position
Eppendorf Realplex4 cycler / original author / Editor / thermal cycler / Farmer / MP / Author / model / Cao / Schumacher RT / /
Complexity of the Inoculum Determines the Rate of Reversion of SIV Gag CD8 T Cell Mutant Virus and Outcome of Infection Liyen Loh1, Jeanette C. Reece1, Caroline S. Fernandez1, Sheilajen Alcantara1, Robert Center1, Jane H